The microRNA miR-31 inhibits CD8 + T cell function in chronic viral infection

Nature Immunology

Volumn 18, Issue 7, 2017, Pages 791-799

  Moffett, Howell F ^a   Cartwright, Adam N R ^a   Kim, Hye Jung ^a   Godec, Jernej ^b   Pyrdol, Jason ^a   Äijö, Tarmo ^c   Martinez, Gustavo J ^d,f   Rao, Anjana ^d   Lu, Jun ^e   Golub, Todd R ^e   Cantor, Harvey ^a   Sharpe, Arlene H ^b   Novina, Carl D ^a   Wucherpfennig, Kai W ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c AALTO UNIVERSITY   (Finland)

^d LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^e BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^f ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; INTERFERON; MICRORNA 31; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR NFAT; CYTOKINE; LYMPHOCYTE ANTIGEN RECEPTOR; MICRORNA; MIRN31 MICRORNA, MOUSE; NFATC2 PROTEIN, MOUSE; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; GENE INDUCTION; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; LYMPHOCYTIC CHORIOMENINGITIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS INFECTION; ANIMAL; ARENAVIRUS INFECTION; CHROMATIN IMMUNOPRECIPITATION; DENDRITIC CELL; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENETICS; IMMUNOBLOTTING; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; ANTIBODIES, VIRAL; ARENAVIRIDAE INFECTIONS; CALCIUM; CD8-POSITIVE T-LYMPHOCYTES; CHROMATIN IMMUNOPRECIPITATION; CYTOKINES; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; IMMUNOBLOTTING; INTERFERON TYPE I; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, KNOCKOUT; MICRORNAS; NFATC TRANSCRIPTION FACTORS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ANTIGEN, T-CELL;

EID: 85021093328     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.3755     Document Type: Article

References (68)

1. Wherry, E.J. et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27, 670-684 (2007).
2. Muljo, S.A. et al. Aberrant T cell differentiation in the absence of Dicer. J. Exp. Med. 202, 261-269 (2005).
3. Cobb, B.S. et al. T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer. J. Exp. Med. 201, 1367-1373 (2005).
4. Zhang, N. & Bevan, M.J. Dicer controls CD8+ T-cell activation, migration, and survival. Proc. Natl. Acad. Sci. USA 107, 21629-21634 (2010).
5. Wu, T. et al. Temporal expression of microRNA cluster miR-17-92 regulates effector and memory CD8+ T-cell differentiation. Proc. Natl. Acad. Sci. USA 109, 9965-9970 (2012).
6. Yang, L. et al. miR-146a controls the resolution of T cell responses in mice. J. Exp. Med. 209, 1655-1670 (2012).
7. Taganov, K.D., Boldin, M.P., Chang, K.J. & Baltimore, D. NF-B-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 103, 12481-12486 (2006).
8. Gracias, D.T. et al. The microRNA miR-155 controls CD8+ T cell responses by regulating interferon signaling. Nat. Immunol. 14, 593-602 (2013).
9. Lu, L.F. et al. Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 30, 80-91 (2009).
10. Trifari, S. et al. MicroRNA-directed program of cytotoxic CD8+ T-cell differentiation. Proc. Natl. Acad. Sci. USA 110, 18608-18613 (2013).
11. Bronevetsky, Y. et al. T cell activation induces proteasomal degradation of Argonaute and rapid remodeling of the microRNA repertoire. J. Exp. Med. 210, 417-432 (2013).
12. Monticelli, S. & Rao, A. NFAT1 and NFAT2 are positive regulators of IL-4 gene transcription. Eur. J. Immunol. 32, 2971-2978 (2002).
13. Martinez, G.J. et al. The transcription factor NFAT promotes exhaustion of activated CD8+ T cells. Immunity 42, 265-278 (2015).
14. Scott-Browne, J.P. et al. Dynamic changes in chromatin accessibility occur in CD8+ T cells responding to viral infection. Immunity 45, 1327-1340 (2016).
15. Alexiou, P., Maragkakis, M., Papadopoulos, G.L., Reczko, M. & Hatzigeorgiou, A.G. Lost in translation: an assessment and perspective for computational microRNA target identification. Bioinformatics 25, 3049-3055 (2009).
16. Baek, D. et al. The impact of microRNAs on protein output. Nature 455, 64-71 (2008).
17. Selbach, M. et al. Widespread changes in protein synthesis induced by microRNAs. Nature 455, 58-63 (2008).
18. Lim, L.P. et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433, 769-773 (2005).
19. Wu, D., Wang, B., Shang, J., Song, J. & Zhang, H. miR-31 reduces cell growth of papillary thyroid carcinoma by RNA-binding protein HuR. Clin. Lab. 61, 1625-1634 (2015).
20. Creighton, C.J. et al. Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers. Cancer Res. 70, 1906-1915 (2010).
21. Ivanov, S.V. et al. Pro-tumorigenic effects of miR-31 loss in mesothelioma. J. Biol. Chem. 285, 22809-22817 (2010).
22. Liu, X. et al. MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J. Clin. Invest. 120, 1298-1309 (2010).
23. Rutledge, H. et al. Identification of microRNAs associated with allergic airway disease using a genetically diverse mouse population. BMC Genomics 16, 633 (2015).
24. Chen, J.H. et al. Prostaglandin E2 and programmed cell death 1 signaling coordinately impair CTL function and survival during chronic viral infection. Nat. Med. 21, 327-334 (2015).
25. Singer, M., Wang, C., Cong, L., Marjanovic, N.D., Kowalczyk, M.S. & Zhang, H. et al. A distinct gene module for dysfunction uncoupled from activation in tumor-infiltrating T cells. Cell 166, 1500-1511 (2016).
26. Ivashkiv, L.B. & Donlin, L.T. Regulation of type I interferon responses. Nat. Rev. Immunol. 14, 36-49 (2014).
27. McNally, J.M. et al. Attrition of bystander CD8 T cells during virus-induced T-cell and interferon responses. J. Virol. 75, 5965-5976 (2001).
28. Marshall, H.D., Urban, S.L. & Welsh, R.M. Virus-induced transient immune suppression and the inhibition of T cell proliferation by type I interferon. J. Virol. 85, 5929-5939 (2011).
29. Terawaki, S. et al. IFN- directly promotes programmed cell death-1 transcription and limits the duration of T cell-mediated immunity. J. Immunol. 186, 2772-2779 (2011).
30. Stefansson, B. & Brautigan, D.L. Protein phosphatase PP6 N terminal domain restricts G1 to S phase progression in human cancer cells. Cell Cycle 6, 1386-1392 (2007).
31. Kajino, T. et al. Protein phosphatase 6 down-regulates TAK1 kinase activation in the IL-1 signaling pathway. J. Biol. Chem. 281, 39891-39896 (2006).
32. Lee, M.N. et al. Identification of regulators of the innate immune response to cytosolic DNA and retroviral infection by an integrative approach. Nat. Immunol. 14, 179-185 (2013).
33. Barber, D.L. et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682-687 (2006).
34. Teijaro, J.R. et al. Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science 340, 207-211 (2013).
35. Wilson, E.B. et al. Blockade of chronic type I interferon signaling to control persistent LCMV infection. Science 340, 202-207 (2013).
36. Punkosdy, G.A. et al. Regulatory T-cell expansion during chronic viral infection is dependent on endogenous retroviral superantigens. Proc. Natl. Acad. Sci. USA 108, 3677-3682 (2011).
37. Penaloza-MacMaster, P. et al. Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection. J. Exp. Med. 211, 1905-1918 (2014).
38. Rouas, R. et al. Human natural Treg microRNA signature: role of microRNA-31 and microRNA-21 in FOXP3 expression. Eur. J. Immunol. 39, 1608-1618 (2009).
39. Zhang, L. et al. MicroRNA-31 negatively regulates peripherally derived regulatory T-cell generation by repressing retinoic acid-inducible protein 3. Nat. Commun. 6, 7639 (2015).
40. Xue, F. et al. miR-31 regulates interleukin 2 and kinase suppressor of ras 2 during T cell activation. Genes Immun. 14, 127-131 (2013).
41. Fan, W. et al. Identification of microRNA-31 as a novel regulator contributing to impaired interleukin-2 production in T cells from patients with systemic lupus erythematosus. Arthritis Rheum. 64, 3715-3725 (2012).
42. Wang, Y. et al. Timing and magnitude of type I interferon responses by distinct sensors impact CD8 T cell exhaustion and chronic viral infection. Cell Host Microbe 11, 631-642 (2012).
43. Bahl, K. et al. IFN-induced attrition of CD8 T cells in the presence or absence of cognate antigen during the early stages of viral infections. J. Immunol. 176, 4284-4295 (2006).
44. Marshall, H.D., Urban, S.L. & Welsh, R.M. Virus-induced transient immune suppression and the inhibition of T cell proliferation by type I interferon. J. Virol. 85, 5929-5939 (2011).
45. Terawaki, S. et al. IFN-directly promotes programmed cell death-1 transcription and limits the duration of T cell-mediated immunity. J. Immunol. 186, 2772-2779 (2011).
46. Xue, F. et al. miR-31 regulates interleukin 2 and kinase suppressor of ras 2 during T cell activation. Genes Immun. 14, 127-131 (2013).
47. Crow, M.K. Type I interferon in the pathogenesis of lupus. J. Immunol. 192, 5459-5468 (2014).
48. Fan, W. et al. Identification of microRNA-31 as a novel regulator contributing to impaired interleukin-2 production in T cells from patients with systemic lupus erythematosus. Arthritis Rheum. 64, 3715-3725 (2012).
49. Welsh, R.M. & Seedhom, M.O. Lymphocytic choriomeningitis virus (LCMV): propagation, quantitation, and storage. Current Protocols in Microbiology Ch 15, Unit 15A 11 (2008).
50. Stamm, A., Valentine, L., Potts, R. & Premenko-Lanier, M. An intermediate dose of LCMV clone 13 causes prolonged morbidity that is maintained by CD4+ T cells. Virology 425, 122-132 (2012).
51. Laidlaw, B.J. et al. Cooperativity between CD8+ T cells, non-neutralizing antibodies, and alveolar macrophages is important for heterosubtypic influenza virus immunity. PLoS Pathog. 9, e1003207 (2013).
52. Decman, V. et al. Cell-intrinsic defects in the proliferative response of antiviral memory CD8 T cells in aged mice upon secondary infection. J. Immunol. 184, 5151-5159 (2010).
53. Mueller, S.N. et al. Qualitatively different memory CD8+ T cells are generated after lymphocytic choriomeningitis virus and influenza virus infections. J. Immunol. 185, 2182-2190 (2010).
54. Wherry, E.J., Blattman, J.N., Murali-Krishna, K., van der Most, R. & Ahmed, R. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77, 4911-4927 (2003).
55. Call, M.J. et al. In vivo enhancement of peptide display by MHC class II molecules with small molecule catalysts of peptide exchange. J. Immunol. 182, 6342-6352 (2009).
56. Martinez, G.J. et al. The transcription factor NFAT promotes exhaustion of activated CD8+ T cells. Immunity 42, 265-278 (2015).
57. Kent, W.J. et al. The human genome browser at UCSC. Genome Res. 12, 996-1006 (2002).
58. Rosenbloom, K.R. et al. ENCODE data in the UCSC Genome Browser: year 5 update. Nucleic Acids Res. 41, D56-D63 (2013).
59. Okamura, H. et al. Concerted dephosphorylation of the transcription factor NFAT1 induces a conformational switch that regulates transcriptional activity. Mol. Cell 6, 539-550 (2000).
60. Lu, J. et al. MicroRNA expression profiles classify human cancers. Nature 435, 834-838 (2005).
61. Reich, M. et al. GenePattern 2.0. Nat. Genet. 38, 500-501 (2006).
62. Schadt, E.E., Li, C., Ellis, B. & Wong, W.H. Feature extraction and normalization algorithms for high-density oligonucleotide gene expression array data. J. Cell. Biochem. Suppl. 37, 120-125 (2001).
63. Tusher, V.G., Tibshirani, R. & Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98, 5116-5121 (2001).
64. Miranda, K.C. et al. A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 126, 1203-1217 (2006).
65. Friedman, R.C., Farh, K.K., Burge, C.B. & Bartel, D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19, 92-105 (2009).
66. Betel, D., Koppal, A., Agius, P., Sander, C. & Leslie, C. Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol. 11, R90 (2010).
67. Yang, J.H. et al. starBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data. Nucleic Acids Res. 39, D202-D209 (2011).
68. Krek, A. et al. Combinatorial microRNA target predictions. Nat. Genet. 37, 495-500 (2005).